Researchers believe a usually harmless virus could trigger Parkinson’s disease. The Human Pegivirus (HPgV) belongs to the ...

Researchers at Northwestern Medicine have discovered that a virus that has flown under the radar for years might be a potential contributor to the neurodegenerative disorder.

New research shows that inhibiting overactive LRRK2 enzymes could stabilize Parkinson's disease progression, with Stanford ...

A decades-old cough medicine, Ambroxol, could be on the verge of a dramatic second act—not for sore throats, but for ...

In a small clinical trial in Canada, a medicine commonly found in European cough syrups has shown early signs it might do ...

Ambroxol, a cough medication, may help stabilize the neuropsychiatric symptoms of Parkinson's disease dementia, a new study ...

Parkinson's disease affects approximately 10 million people worldwide. It typically begins asymmetrically, initially ...

The results of experiments in mice models were "astounding," said biochemist Suzanne Pfeffer of Stanford University.

A breakthrough brain scan shows Parkinson’s drugs can misfire in the brain, helping some patients less than others. The fix?

A study links living near golf courses to higher Parkinson's risk, with strongest association found in those one to three ...

These findings highlight the significance of rearing behavior and behavioral lateralization as potential behavioral markers ...